Title | Type | SJR | H index | Total Docs. (2000) | Total Docs. (3years) | Total Refs. (2000) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2000) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Critical Reviews in Toxicology | journal | 2.041 Q1 | 129 | 12 | 46 | 3053 | 316 | 45 | 6.88 | 254.42 | |
2 | Natural Product Reports | journal | 2.895 Q1 | 211 | 38 | 112 | 6619 | 543 | 112 | 5.00 | 174.18 | |
3 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 0.860 Q1 | 99 | 9 | 26 | 1490 | 75 | 26 | 2.88 | 165.56 | |
4 | Reviews in Contemporary Pharmacotherapy | journal | 0.229 Q3 | 18 | 17 | 93 | 2155 | 94 | 93 | 1.13 | 126.76 | |
5 | Expert Opinion on Therapeutic Targets | journal | 0.146 Q3 | 106 | 44 | 158 | 5137 | 29 | 156 | 0.32 | 116.75 | |
6 | Drug Safety | journal | 0.961 Q1 | 140 | 75 | 226 | 6578 | 812 | 219 | 3.38 | 87.71 | |
7 | IDrugs : the investigational drugs journal | journal | 0.144 Q3 | 39 | 69 | 241 | 5920 | 63 | 237 | 0.26 | 85.80 | |
8 | Expert Opinion on Emerging Drugs | journal | 0.243 Q3 | 54 | 25 | 63 | 2057 | 49 | 61 | 0.80 | 82.28 | |
9 | Clinical Pharmacokinetics | journal | 1.632 Q1 | 184 | 68 | 207 | 5484 | 1126 | 200 | 4.40 | 80.65 | |
10 | Toxicology and Industrial Health | journal | 0.556 Q2 | 69 | 34 | 170 | 2662 | 290 | 168 | 1.98 | 78.29 | |
11 | Expert Opinion on Pharmacotherapy | journal | 0.119 Q4 | 93 | 89 | 16 | 6820 | 4 | 16 | 0.25 | 76.63 | |
12 | Toxin Reviews | journal | 0.336 Q3 | 54 | 12 | 92 | 873 | 73 | 89 | 0.77 | 72.75 | |
13 | Expert Opinion on Investigational Drugs | journal | 0.365 Q2 | 117 | 278 | 449 | 19174 | 510 | 446 | 1.17 | 68.97 | |
14 | BioDrugs | journal | 0.187 Q3 | 79 | 81 | 251 | 5271 | 174 | 240 | 0.79 | 65.07 | |
15 | Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs | journal | 5 | 35 | 0 | 2174 | 0 | 0 | 0.00 | 62.11 | ||
16 | Pharmacogenomics | journal | 100 | 35 | 0 | 1937 | 0 | 0 | 0.00 | 55.34 | ||
17 | Current Opinion in Drug Discovery and Development | journal | 0.669 Q1 | 85 | 77 | 83 | 3924 | 161 | 78 | 1.94 | 50.96 | |
18 | Current Opinion in Molecular Therapeutics | journal | 0.283 Q3 | 67 | 90 | 93 | 4584 | 63 | 87 | 0.68 | 50.93 | |
19 | Neuropsychopharmacology | journal | 1.965 Q1 | 249 | 153 | 369 | 7399 | 1630 | 336 | 4.47 | 48.36 | |
20 | Expert Opinion on Therapeutic Patents | journal | 0.439 Q2 | 88 | 150 | 402 | 6755 | 392 | 397 | 1.04 | 45.03 | |
21 | Receptors and Channels | journal | 1.269 Q1 | 44 | 19 | 76 | 846 | 137 | 76 | 1.94 | 44.53 | |
22 | Neuropharmacology | journal | 2.141 Q1 | 191 | 283 | 546 | 12355 | 2431 | 542 | 4.11 | 43.66 | |
23 | International Journal of Neuropsychopharmacology | journal | 0.432 Q2 | 125 | 47 | 66 | 1989 | 65 | 66 | 0.98 | 42.32 | |
24 | Journal of Autonomic Pharmacology | journal | 26 | 36 | 132 | 1516 | 108 | 132 | 0.87 | 42.11 | ||
25 | Mutagenesis | journal | 0.772 Q1 | 102 | 74 | 269 | 3062 | 557 | 267 | 1.90 | 41.38 | |
26 | PharmacoEconomics | journal | 0.623 Q2 | 118 | 113 | 412 | 4645 | 734 | 381 | 1.74 | 41.11 | |
27 | Toxicological Sciences | journal | 0.626 Q2 | 207 | 302 | 502 | 12091 | 1192 | 496 | 2.34 | 40.04 | |
28 | Antiviral Chemistry and Chemotherapy | journal | 0.650 Q2 | 59 | 38 | 160 | 1506 | 338 | 159 | 2.39 | 39.63 | |
29 | Journal of Psychopharmacology | journal | 1.122 Q1 | 135 | 72 | 223 | 2831 | 629 | 197 | 2.05 | 39.32 | |
30 | Tetrahedron | journal | 1.536 Q1 | 236 | 1087 | 3738 | 41262 | 8626 | 3728 | 2.42 | 37.96 | |
31 | Cytokines, Cellular and Molecular Therapy | journal | 0.626 Q2 | 28 | 29 | 82 | 1099 | 145 | 81 | 1.67 | 37.90 | |
32 | Environmental Pollution | journal | 0.855 Q1 | 301 | 215 | 612 | 8101 | 853 | 606 | 1.17 | 37.68 | |
33 | Progress in Pharmaceutical and Biomedical Analysis | book series | 8 | 49 | 0 | 1799 | 0 | 0 | 0.00 | 36.71 | ||
34 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.498 Q2 | 92 | 37 | 111 | 1330 | 179 | 111 | 1.84 | 35.95 | |
35 | Clinical and Experimental Pharmacology and Physiology | journal | 0.660 Q1 | 115 | 184 | 604 | 6587 | 1007 | 603 | 1.65 | 35.80 | |
36 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.303 Q3 | 81 | 59 | 186 | 2060 | 150 | 169 | 0.93 | 34.92 | |
37 | Bioorganic and Medicinal Chemistry | journal | 0.846 Q1 | 187 | 280 | 774 | 9765 | 1405 | 773 | 1.81 | 34.88 | |
38 | Drug Design and Discovery | journal | 0.584 Q2 | 20 | 33 | 47 | 1135 | 58 | 47 | 1.27 | 34.39 | |
39 | Alimentary Pharmacology and Therapeutics, Supplement | journal | 0.877 Q1 | 69 | 59 | 71 | 2024 | 208 | 62 | 3.56 | 34.31 | |
40 | Toxicology Mechanisms and Methods | journal | 0.121 Q4 | 55 | 36 | 134 | 1233 | 64 | 128 | 0.43 | 34.25 | |
41 | Immunopharmacology and Immunotoxicology | journal | 0.311 Q3 | 61 | 45 | 128 | 1523 | 129 | 128 | 0.95 | 33.84 | |
42 | Toxicology in Vitro | journal | 0.313 Q3 | 125 | 62 | 285 | 2087 | 241 | 282 | 0.78 | 33.66 | |
43 | Journal of Toxicology and Environmental Health - Part A: Current Issues | journal | 0.494 Q2 | 99 | 151 | 239 | 5060 | 357 | 235 | 1.49 | 33.51 | |
44 | Fundamental and Clinical Pharmacology | journal | 0.410 Q2 | 85 | 62 | 276 | 2075 | 282 | 273 | 1.25 | 33.47 | |
45 | Alcohol and Alcoholism | journal | 0.475 Q2 | 109 | 105 | 269 | 3485 | 360 | 245 | 1.26 | 33.19 | |
46 | Inhalation Toxicology | journal | 0.344 Q3 | 97 | 171 | 174 | 5654 | 183 | 169 | 0.92 | 33.06 | |
47 | International Antiviral News | journal | 0.249 Q3 | 8 | 23 | 103 | 756 | 40 | 69 | 0.44 | 32.87 | |
48 | Journal of Peptide Science | journal | 0.668 Q1 | 73 | 61 | 148 | 1971 | 196 | 145 | 1.49 | 32.31 | |
49 | Food and Chemical Toxicology | journal | 0.516 Q2 | 203 | 146 | 378 | 4703 | 589 | 368 | 1.48 | 32.21 | |
50 | Journal of Exposure Science and Environmental Epidemiology | journal | 0.622 Q2 | 106 | 73 | 130 | 2310 | 203 | 127 | 1.48 | 31.64 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®